TL;DR
Research protocols for investigating GHK-Cu in dermal biology contexts — fibroblast cultures, collagen assays, gene expression studies, and wound closure kinetics.
Research use only. This guide summarizes published research methodology for educational purposes. All Aureum Peptides products are sold strictly for in-vitro laboratory research.
GHK-Cu in Fibroblast Culture
Standard dermal fibroblast cultures (HDF) at concentrations of 10 nM – 1 µM GHK-Cu are commonly used to study cell proliferation, migration, and collagen synthesis. Matrix assays (Sircol) can quantify collagen production changes under GHK-Cu vs vehicle control.
Gene Expression Microarray Studies
Published microarray studies report GHK-Cu modulates expression of approximately 4,000 genes in dermal contexts, with notable upregulation of DNA repair (BRCA1, XRCC1), collagen synthesis (COL1A1), and matrix remodeling pathways. qPCR validation with specific target panels is common follow-up methodology.
Wound Closure Kinetics (Scratch Assay)
Scratch wound assays in confluent fibroblast or keratinocyte monolayers at 0.1–1 µM GHK-Cu — timelapse imaging at 2h, 6h, 12h, 24h. Compare wound-edge closure velocity vs vehicle control. Published assays consistently show modestly accelerated closure.
In Vivo Rodent Excision Models
Full-thickness rodent excision wounds with topical GHK-Cu formulations — standard assessment at days 3, 7, 14 for closure rate, granulation tissue depth, and collagen density via histology.
Reconstitution Specific Notes
GHK-Cu is supplied as a copper-complexed form; dissolution in bacteriostatic water is standard. Protect from prolonged UV exposure (copper complex photosensitivity). Typical research concentrations 0.5–2 mg/mL.
Research-Grade Material from Aureum
Aureum Peptides provides research-grade peptides with ≥99% HPLC-verified purity and batch-specific Certificate of Analysis. Same-day dispatch on qualified orders placed before 2:00 PM EST.
Related guides:
Disclaimer: Educational content for qualified researchers. Not research information. No therapeutic claims. Peptides not approved by FDA for human use. For in-vitro laboratory research purposes only.
Last reviewed: 2026-04-21
